We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Kirin Settles Suit Vs. Geron Over Cancer Vaccine Development Rights

Law360 (June 22, 2004, 12:00 AM EDT) -- Japanese pharmaceutical and brewing company Kirin Brewery has settled its litigation against Geron Corp. over development rights to cancer vaccines.

The lawsuit has been dismissed, and the out-of-court settlement does not involve any payment by either party, Geron said in a statement.

There will be no effect on the licensing agreement between Geron and Merix Bioscience, and Kirin has subsequently entered into a global partnership with Merix for research and development activity relating to cancer therapies.

Kirin will make a $5 million investment to buy a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.